Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a home feeding coach keep dementia patients out of the hospital?

NCT ID NCT06727461

Disease control Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether an 8-week home-based program called FEED@Home can reduce hospital readmissions for people with advanced dementia who have feeding difficulties. The program involves speech therapists and nurses guiding family caregivers through teleconsultations and home visits to improve feeding techniques. Researchers will compare this approach to usual care, tracking readmissions and other outcomes like feeding problems, nutrition, and caregiver burden over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
FEED@Home program: an 8-week home-based intervention led by speech therapists and nurses, including teleconsultations and home visits to guide caregivers on feeding techniques.
What this could lead to
If effective, this program could reduce hospital readmissions and improve quality of life for dementia patients with feeding problems, while easing caregiver burden.
What could go wrong
This is a relatively small trial, and results may not apply to all dementia patients. The program's success depends on caregiver adherence and individual patient responses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Subjects are dyads of dementia patients and family caregivers. Inclusion Criteria (For patients): * Age ≥ 60 years old * Diagnosis of dementia based on DSM-5 Criteria for Major Neurocognitive Disorder * Moderately severe to severe dementia as defined by Stage 6 or above on the Functional Assessment Staging Test * Has indication for tube feeding due to severe feeding difficulties identified by the medical team (cognitive feeding issues and/or oropharyngeal dysphagia) and family surrogate opted for oral feeding * Maintained on oral feeding at the time of discharge * Reside at home after discharge * Has available legally authorized representative (e.g. next of kin) who can provide informed consent for patient Exclusion Criteria(For patients): * Any type of feeding tube at time of discharge * Discharged to residential care homes, respite care or hospice facilities * No available family caregiver at home Inclusion Criteria (For family caregivers ): * Age ≥ 18 years old or above * Main caregiver who provides or supervises feeding assistance to the patient for ≥70% of meals * Able to provide informed consent Exclusion Criteria (For family caregivers ): No specific exclusion criteria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dementia Dementia severe

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Queen Mary Hospital

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.